AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionLaffer Investments
Latest Disclosed Ownership70,564 shares
Latest Disclosed Value $ 15,347,091
Laffer Investments reports 2.87% increase in ownership of 4AB / AbbVie Inc.

On May 13, 2026 - Laffer Investments filed a 13F-HR form disclosing ownership of 70,564 shares of AbbVie Inc. (BG:4AB) valued at $15,347,091 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 68,592 shares of AbbVie Inc.. This represents a change in shares of 2.87% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F ABBVIE COM 00287Y109 70,564 1,972 2.87 15,347 -2.07 2.2661
2026-02-12 2025-12-31 13F ABBVIE COM 00287Y109 68,592 3,526 5.42 15,673 4.03 2.3818
2025-11-12 2025-09-30 13F ABBVIE COM 00287Y109 65,066 2,868 4.61 15,066 30.49 2.3857
2025-08-07 2025-06-30 13F ABBVIE COM 00287Y109 62,198 -3,840 -5.81 11,545 -16.56 2.0575
2025-05-14 2025-03-31 13F ABBVIE COM 00287Y109 66,038 1,657 2.57 13,836 20.94 2.9459
2025-02-06 2024-12-31 13F ABBVIE COM 00287Y109 64,381 7,853 13.89 11,440 2.48 2.2495
2024-11-04 2024-09-30 13F ABBVIE COM 00287Y109 56,528 1,432 2.60 11,163 18.13 2.2607
2024-08-14 2024-06-30 13F ABBVIE COMMON STOCKS 00287Y109 55,096 11,764 27.15 9,450 19.77 2.0368
2024-05-15 2024-03-31 13F ABBVIE COMMON STOCKS 00287Y109 43,332 -3,153 -6.78 7,891 9.54 2.0371
2024-02-08 2023-12-31 13F ABBVIE COMMON STOCKS 00287Y109 46,485 2,858 6.55 7,204 10.76 1.9150
2023-11-14 2023-09-30 13F ABBVIE COMMON STOCKS 00287Y109 43,627 -3,037 -6.51 6,503 3.44 1.9122
2023-08-14 2023-06-30 13F ABBVIE COMMON STOCKS 00287Y109 46,664 1,869 4.17 6,287 -11.92 1.6680
2023-05-09 2023-03-31 13F ABBVIE COMMON STOCKS 00287Y109 44,795 1,315 3.02 7,139 1.59 1.9340
2023-02-10 2022-12-31 13F ABBVIE COMMON STOCKS 00287Y109 43,480 9,781 29.02 7,027 55.37 2.0223
2022-11-10 2022-09-30 13F abbvie COMMON STOCKS 00287Y109 33,699 1,435 4.45 4,523 -8.48 1.6619
2022-08-15 2022-06-30 13F abbvie COMMON STOCKS 00287Y109 32,264 -156 -0.48 4,942 -5.98 1.7351
2022-05-13 2022-03-31 13F abbvie COMMON STOCKS 00287Y109 32,420 -2,736 -7.78 5,256 10.40 1.5834
2022-02-11 2021-12-31 13F abbvie COMMON STOCKS 00287Y109 35,156 1,043 3.06 4,760 29.38 1.3747
2021-11-16 2021-09-30 13F abbvie COMMON STOCKS 00287Y109 34,113 7,568 28.51 3,680 23.04 1.0647
2021-08-16 2021-06-30 13F abbvie COMMON STOCKS 00287Y109 26,545 3,527 15.32 2,990 20.03 1.1204
2021-05-17 2021-03-31 13F ABBVIE INC COM COMMON STOCKS 00287Y109 23,018 1,690 7.92 2,491 10.96 0.9430
2021-06-11 2020-12-31 13F/A-1 ABBVIE INC COM COMMON STOCKS 00287Y109 21,328 1,679 8.54 2,245 30.45 0.9470
2021-02-19 2020-12-31 13F ABBVIE INC COM COMMON STOCKS 00287Y109 20,556 907 2,203 1.0689
2021-06-11 2020-09-30 13F/A-1 ABBVIE INC COM COMMON STOCKS 00287Y109 19,649 -1,491 -7.05 1,721 -17.06 0.8606
2020-11-13 2020-09-30 13F Abbvie COMMON STOCKS 00287Y109 19,610 -1,530 1,718 0.8382
2021-06-11 2020-06-30 13F/A-1 ABBVIE INC COM COMMON STOCKS 00287Y109 21,140 3,089 17.11 2,076 50.91 1.1927
2020-08-14 2020-06-30 13F Abbvie COMMON STOCKS 00287Y109 21,208 3,157 2,082 1.3272
2020-04-28 2020-03-31 13F Abbvie COMMON STOCKS 00287Y109 18,051 3,095 20.69 1,375 3.85 1.0729
2020-02-20 2019-12-31 13F Abbvie COMMON STOCKS 00287Y109 14,956 7,040 88.93 1,324 121.04 0.8813
2019-11-14 2019-09-30 13F Abbvie COMMON STOCKS 00287Y109 7,916 -146 -1.81 599 2.22 0.5118
2019-08-15 2019-06-30 13F Abbvie COMMON STOCKS 00287Y109 8,062 129 1.63 586 -8.29 0.5018
2019-05-14 2019-03-31 13F Abbvie COMMON STOCKS 00287Y109 7,933 7,933 639 0.1719
2017-02-15 2016-12-31 13F Abbvie COMMON STOCKS 00287Y109 0 -38,166 -100.00 0 -100.00
2016-11-15 2016-09-30 13F Abbvie COMMON STOCKS 00287Y109 38,166 0 0.00 2,407 1.91 0.6691
2016-08-15 2016-06-30 13F Abbvie COMMON STOCKS 00287Y109 38,166 38,166 0.00 2,363 0.6714
2015-02-17 2014-12-31 13F Abbvie COMMON STOCKS 00287Y109 0 -56 -100.00 0 -100.00
2014-11-14 2014-09-30 13F Abbvie COMMON STOCKS 00287Y109 56 56 -99.87 3 -100.00 0.0005
2013-11-14 2013-09-30 13F AbbVie COMMON STOCKS 00287Y109 0 -42,240 -100.00 0 -100.00
2013-08-15 2013-06-30 13F AbbVie COMMON STOCKS 00287Y109 42,240 42,240 1,746 0.3421
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.